The controlled, randomised clinical trial -- sacred duty or sacred cow?

F T de Dombal. Klin Wochenschr. 1980.

. 1980 Jul 1;58(13):649-52.

doi: 10.1007/BF01478602.

No abstract available

Similar articles

The design of controlled experiments in the evaluation of non-therapeutic interventions.
Buck C, Donner A. Buck C, et al. J Chronic Dis. 1982;35(7):531-8. doi: 10.1016/0021-9681(82)90072-8. J Chronic Dis. 1982. PMID: 7085845 No abstract available.
Misuse of randomized clinical trials.
Hofmann F. Hofmann F. Man Med. 1979;4(2):138-42. Man Med. 1979. PMID: 12083135 No abstract available.
The landscape and lexicon of blinding in randomized trials.
Schulz KF, Chalmers I, Altman DG. Schulz KF, et al. Ann Intern Med. 2002 Feb 5;136(3):254-9. doi: 10.7326/0003-4819-136-3-200202050-00022. Ann Intern Med. 2002. PMID: 11827510 No abstract available.
Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials.
Feinstein AR. Feinstein AR. J Clin Epidemiol. 1989;42(6):481-9; discussion 499-502. doi: 10.1016/0895-4356(89)90142-x. J Clin Epidemiol. 1989. PMID: 2661727 Review. No abstract available.
Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?
Webster RK, Bishop F, Collins GS, Evers AWM, Hoffmann T, Knottnerus JA, Lamb SE, Macdonald H, Madigan C, Napadow V, Price A, Rees JL, Howick J. Webster RK, et al. J Clin Epidemiol. 2021 Jul;135:176-181. doi: 10.1016/j.jclinepi.2021.02.022. Epub 2021 Mar 1. J Clin Epidemiol. 2021. PMID: 33662512 Review.